Juva Life Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Juva Life Inc. (JUVAF) acquires, owns, and operates cannabis businesses in the medical and recreational sectors in California, United States; the company operates through two reportable segments comprising the resale of merchandise and cannabis-derived products including high-quality flower, pre-rolled products under the Flōs brand, rosin absolute vapes, infused flower offerings, and delivery services, as well as the cultivation and sale of trim and flowers from its Stockton facility; it also conducts pharmaceutical research and development on cannabis-based therapeutics such as the anti-inflammatory compounds Juva-019, Juva-041, and novel cannabinoid profiles for pain management and inflammation, alongside consumer-facing operations in retail storefronts, extraction, testing, formulation, and the JuLi Registry patient study for real-world clinical data. Founded in 2018 and headquartered in Vancouver, Canada, Juva Life focuses on the life sciences and cannabis industry, targeting budget-conscious consumers, medical patients, and pharmaceutical applications primarily in California with statewide distribution. In recent developments, the company secured $11.8 million in non-dilutive financing in 2023 from Pelorus Equity Group to acquire its Stockton cultivation facility and advance clinical research on Juva-019 and Juva-041, launched the Flōs product line and Rosin Absolute vapes, and completed facility expansions; however, it defaulted on the $11.8 million secured promissory note and other debts in 2024 amid operational challenges including virus-affected plants, mechanical issues, wholesale price drops, and SEC compliance problems, resulting in employee layoffs, cessation of Stockton operations on October 31, 2024, trading suspensions, CFO Mat Lee resignation on November 18, 2024, CEO Douglas Chloupek resignation on November 22, 2024, and court-appointed receivership on November 7, 2024, under Kevin Singer to oversee asset liquidation and corporate dissolution.
Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings
Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing
Juva Life Unveils New Cannabis Vape Category - Rosin Absolute - Introduces Infused Flower Offerings and Announces Partnership With Cloudius9
Juva Life Reports Strong Growth in Q3 2023 Financial Results
Juva Life Inc. (JUVAF) Q2 2022 Earnings Call Transcript
Juva Life Files Patent on Family of Non-Cannabinoid Small Molecules Targeting Consumer and Pharma Inflammatory Indications
Juva Life Announces Top Line R/D Data and Initiates Optimization & Development of Juva-019
Juva Life CEO Doug Chloupek to Present Live on May 25
Juva Life Sells Subsidiary Facility and Offers a Look at Stockton Cultivation and Delivery Activity
Juva Life Enrolls First Human Subject in Cannabis Registry Study
Juva Life Commences Industrial Scale Cannabis Cultivation at Stockton Facility
Juva Life Advances Intellectual Property Protection Program and Advises on DTC Eligibility
Juva Life Initiates Clinical Registry as First Step in Building Evidence-Based Cannabis Technology Platform
Juva Life Receives California Cultivation License for Stockton Facility
Juva Life Unifies and Accelerates Brand Marketing Plans
Juva Life Brings Bold Outlook for the New Year